CD34 positive cells, rare stem cells in human blood, can self-renew and transform into various blood cell types. Essential in treating lymphoma, leukemia, and blood disorders through hematopoietic stem cell transplantation (HSCT), they are typically isolated from peripheral blood, making the process less invasive. Their potential extends to treating neurological and autoimmune diseases, with gene editing technologies promising future advancements.
For more information, visit https://www.flickr.com/photos/....145630917@N05/538146
Like
Comment
Share
